Participated · Series C · Jan 2022

Enable Injections is a Cincinnati, OH-based healthcare company focused on improving the patient treatment experience with its enFuse On-Body Delivery System (OBDS), which enables subcutaneous administration of large-volume drugs. The technology aims to replace lengthy intravenous infusions with a discreet, wearable device that patients can use outside clinical settings. To scale production, the company announced plans in February 2024 for a 90,000-square-foot Manufacturing Center of Excellence in Springdale, Ohio, alongside upgrades to its Evendale headquarters. Enable Injections closed a $215 million Series C round in January 2022 led by Magnetar Capital, with participation from Sanofi and other institutional and regional investors. In January 2026, Sanofi committed an additional $30 million, underscoring strategic support for the commercialization of enFuse. The new capital will be used to consolidate supply-chain capabilities and accelerate commercial growth. These funds position Enable Injections to advance toward full-scale manufacturing and market launch of its OBDS platform.

Participated · Series C · Apr 2021

Groq has repositioned itself from a semiconductor maker into a provider of AI inference compute infrastructure following the sale of most of its chip assets to Nvidia in late 2025. After that transaction Groq's previous leadership and a majority of its engineering team moved to Nvidia. The company currently operates a network of 13 data centers and plans to expand total capacity to roughly 200 megawatts by the end of 2027. Groq raised $650 million in the most recent financing led by Disruptive and Infinitum to fund that expansion. In September 2025 it previously raised $750 million at a $6.9 billion valuation with investors that included Samsung, Cisco and BlackRock. Groq is positioning itself to address growing demand for reliable, cost-efficient inference services for deployed AI models.

Led · Seed · Jan 2017

Prattle develops sentiment analysis products that quantify the relationship between language and market movements for finance professionals. The company employs natural language processing, sentiment analysis and machine learning and uses a patent-pending methodology to algorithmically generate data designed to predict market impact of central bank and corporate communications. Its data is delivered in real time through an interactive web portal, email notifications and an API. Research analysts, traders and other finance professionals use Prattle data to anticipate and spot market trends and build data-driven trading strategies. The company will use the $3.3M seed financing to continue building out its proprietary sentiment-analysis products. Prattle is led by CEO Evan Schnidman and is based in St. Louis, MO.